These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11707689)

  • 1. Bucillamine prevents myocardial reperfusion injury.
    Horwitz LD; Sherman NA
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):859-67. PubMed ID: 11707689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion.
    Horwitz LD; Fennessey PV; Shikes RH; Kong Y
    Circulation; 1994 Apr; 89(4):1792-801. PubMed ID: 8149545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bucillamine: a potent thiol donor with multiple clinical applications.
    Horwitz LD
    Cardiovasc Drug Rev; 2003; 21(2):77-90. PubMed ID: 12847560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged administration of a dithiol antioxidant protects against ventricular remodeling due to ischemia-reperfusion in mice.
    Ambler SK; Hodges YK; Jones GM; Long CS; Horwitz LD
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1303-H1310. PubMed ID: 18689493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs.
    Padilla F; Garcia-Dorado D; Agulló L; Barrabés JA; Inserte J; Escalona N; Meyer M; Mirabet M; Pina P; Soler-Soler J
    Cardiovasc Res; 2001 Aug; 51(3):592-600. PubMed ID: 11476750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
    Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained myocardial protection by clentiazem (TA-3090) after a 90-minute coronary occlusion and 72 hours of reperfusion in dogs with collateral flow.
    Rousseau G; Provost P; Latour JG
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):264-72. PubMed ID: 7692168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanthine oxidase inhibition does not limit canine infarct size.
    Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
    Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs.
    Zhang HX; Zang YM; Huo JH; Liang SJ; Zhang HF; Wang YM; Fan Q; Guo WY; Wang HC; Gao F
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):306-13. PubMed ID: 17204910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium.
    Rousseau G; St-Jean G; Latour JG; Merhi Y; Nattel S; Waters D
    Cardiovasc Res; 1991 Apr; 25(4):319-29. PubMed ID: 1884391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury.
    Amersi F; Nelson SK; Shen XD; Kato H; Melinek J; Kupiec-Weglinski JW; Horwitz LD; Busuttil RW; Horwitz MA
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8915-20. PubMed ID: 12084933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Evidence for neutrophil-mediated reperfusion injury.
    Litt MR; Jeremy RW; Weisman HF; Winkelstein JA; Becker LC
    Circulation; 1989 Dec; 80(6):1816-27. PubMed ID: 2598440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion.
    Lee BH; Yi KY; Lee S; Lee S; Yoo SE
    Eur J Pharmacol; 2005 Oct; 523(1-3):101-8. PubMed ID: 16226744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is isoflurane-induced preconditioning dose related?
    Kehl F; Krolikowski JG; Mraovic B; Pagel PS; Warltier DC; Kersten JR
    Anesthesiology; 2002 Mar; 96(3):675-80. PubMed ID: 11873044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals.
    Mitsos SE; Askew TE; Fantone JC; Kunkel SL; Abrams GD; Schork A; Lucchesi BR
    Circulation; 1986 May; 73(5):1077-86. PubMed ID: 3698230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors modifying protective effect of anti-CD18 antibodies on myocardial reperfusion injury in dogs.
    Perez RG; Arai M; Richardson C; DiPaula A; Siu C; Matsumoto N; Hildreth JE; Mariscalco MM; Smith CW; Becker LC
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H53-64. PubMed ID: 8769734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
    Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of treatment for myocardial reperfusion injury.
    Horwitz LD; Kong Y; Robertson AD
    J Cardiovasc Pharmacol; 1999 Jan; 33(1):19-29. PubMed ID: 9890392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.